REXAHN PHARMACEUTICALS, INC. 10-Q 03-31-2012

Company

Opus Genetics, Inc.

Filed

May 9, 2012

Period of Report

March 31, 2012

Accession Number

0001140361-12-023967

A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →